Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A
- PMID: 18979076
- PMCID: PMC2752144
- DOI: 10.1007/s12026-008-8072-7
Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A
Abstract
Natural killer (NK) cells are lymphocytes generally recognized as sentinels of the innate immune system due to their inherent capacity to deal with diseased (stressed) cells, including malignant and infected. This ability to recognize many potentially pathogenic situations is due to the expression of a diverse panel of activation receptors. Because NK cell activation triggers an aggressive inflammatory response, it is important to have a means of throttling this response. Hence, NK cells also express a panel of inhibitory receptors that recognize ligands expressed by "normal" cells. Little or nothing is known about the endocytosis and trafficking of NK cell receptors, which are of great relevance to understanding how NK cells maintain the appropriate balance of activating and inhibitory receptors on their cell surface. In this review, we focus on the ITIM-containing inhibitory receptor CD94/NKG2A showing that it is endocytosed by a previously undescribed macropinocytic-like process that may be related to the maintenance of its surface expression.
Figures


Similar articles
-
Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor.Traffic. 2008 Jun;9(6):1019-34. doi: 10.1111/j.1600-0854.2008.00738.x. Epub 2008 Mar 19. Traffic. 2008. PMID: 18363778
-
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271. Immunology. 2014. PMID: 24673109 Free PMC article. Clinical Trial.
-
Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.J Reprod Immunol. 2006 Jun;70(1-2):33-42. doi: 10.1016/j.jri.2005.12.008. Epub 2006 Feb 20. J Reprod Immunol. 2006. PMID: 16488482
-
The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.Mol Immunol. 2005 Feb;42(4):485-8. doi: 10.1016/j.molimm.2004.07.031. Mol Immunol. 2005. PMID: 15607803 Review.
-
The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.Immunol Res. 2006;35(3):263-78. doi: 10.1385/IR:35:3:263. Immunol Res. 2006. PMID: 17172651 Review.
Cited by
-
Defining early human NK cell developmental stages in primary and secondary lymphoid tissues.PLoS One. 2012;7(2):e30930. doi: 10.1371/journal.pone.0030930. Epub 2012 Feb 3. PLoS One. 2012. PMID: 22319595 Free PMC article.
-
Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking.Cell Death Differ. 2015 Jan;22(1):96-107. doi: 10.1038/cdd.2014.120. Epub 2014 Aug 29. Cell Death Differ. 2015. PMID: 25168239 Free PMC article.
-
Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system.Cancer Cell Int. 2022 Dec 17;22(1):413. doi: 10.1186/s12935-022-02805-6. Cancer Cell Int. 2022. PMID: 36528587 Free PMC article. Review.
-
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity.Mol Ther Oncol. 2024 Sep 2;32(4):200870. doi: 10.1016/j.omton.2024.200870. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39346765 Free PMC article.
-
Critical considerations for targeting colorectal liver metastases with nanotechnology.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1588. doi: 10.1002/wnan.1588. Epub 2019 Sep 30. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020. PMID: 31566913 Free PMC article. Review.
References
-
- Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D, Mingari MC, et al. Human NK cells and their receptors. Microbes Infect. 2002;4:1539–44. - PubMed
-
- Hallett WH, Murphy WJ. Positive and negative regulation of natural killer cells: therapeutic implications. Semin Cancer Biol. 2006;16:367–82. - PubMed
-
- Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol. 2004;5:121–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources